TMDX logo

TransMedics Group, Inc. (TMDX) EBITDA

annual EBITDA:

$69.95M+$77.65M(+1008.05%)
December 31, 2024

Summary

  • As of today (September 18, 2025), TMDX annual EBITDA is $69.95 million, with the most recent change of +$77.65 million (+1008.05%) on December 31, 2024.
  • During the last 3 years, TMDX annual EBITDA has risen by +$108.44 million (+281.74%).
  • TMDX annual EBITDA is now at all-time high.

Performance

TMDX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMDXincome statement metrics

quarterly EBITDA:

$43.30M+$9.72M(+28.94%)
June 30, 2025

Summary

  • As of today (September 18, 2025), TMDX quarterly EBITDA is $43.30 million, with the most recent change of +$9.72 million (+28.94%) on June 30, 2025.
  • Over the past year, TMDX quarterly EBITDA has increased by +$26.19 million (+153.10%).
  • TMDX quarterly EBITDA is now at all-time high.

Performance

TMDX quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMDXincome statement metrics

TTM EBITDA:

$100.30M+$26.19M(+35.34%)
June 30, 2025

Summary

  • As of today (September 18, 2025), TMDX TTM EBITDA is $100.30 million, with the most recent change of +$26.19 million (+35.34%) on June 30, 2025.
  • Over the past year, TMDX TTM EBITDA has increased by +$59.29 million (+144.59%).
  • TMDX TTM EBITDA is now at all-time high.

Performance

TMDX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMDXincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

TMDX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1008.0%+153.1%+144.6%
3 y3 years+281.7%+593.4%+358.8%
5 y5 years+350.4%+678.3%+430.1%

TMDX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+281.7%at high+593.4%at high+358.8%
5 y5-yearat high+281.7%at high+484.2%at high+354.6%
alltimeall timeat high+281.7%at high+484.2%at high+354.6%

TMDX EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$43.30M(+28.9%)
$100.30M(+35.3%)
Mar 2025
-
$33.58M(+134.4%)
$74.11M(+29.2%)
Dec 2024
$69.95M(-1008.0%)
$14.32M(+57.4%)
$57.35M(+16.2%)
Sep 2024
-
$9.10M(-46.8%)
$49.34M(+20.3%)
Jun 2024
-
$17.11M(+1.7%)
$41.01M(+66.6%)
Mar 2024
-
$16.82M(+166.7%)
$24.62M(+242.6%)
Dec 2023
-$7.70M(-73.4%)
$6.31M(+719.2%)
$7.18M(-262.1%)
Sep 2023
-
$770.00K(+7.2%)
-$4.43M(-54.2%)
Jun 2023
-
$718.00K(-217.5%)
-$9.68M(-49.5%)
Mar 2023
-
-$611.00K(-88.5%)
-$19.17M(-29.6%)
Dec 2022
-$28.96M(-24.8%)
-$5.31M(+18.7%)
-$27.24M(-14.8%)
Sep 2022
-
-$4.47M(-49.0%)
-$31.97M(-17.5%)
Jun 2022
-
-$8.78M(+1.1%)
-$38.76M(-1.6%)
Mar 2022
-
-$8.68M(-13.4%)
-$39.40M(+7.1%)
Dec 2021
-$38.49M
-$10.03M(-11.0%)
-$36.78M(+14.2%)
Sep 2021
-
-$11.27M(+19.7%)
-$32.22M(+28.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$9.42M(+55.3%)
-$25.15M(+8.3%)
Mar 2021
-
-$6.06M(+10.9%)
-$23.22M(-6.4%)
Dec 2020
-$23.15M(-17.1%)
-$5.47M(+29.9%)
-$24.81M(-10.4%)
Sep 2020
-
-$4.21M(-43.8%)
-$27.68M(-8.9%)
Jun 2020
-
-$7.49M(-2.1%)
-$30.38M(+0.2%)
Mar 2020
-
-$7.65M(-8.3%)
-$30.31M(+6.8%)
Dec 2019
-$27.93M(+38.1%)
-$8.34M(+20.7%)
-$28.38M(+8.4%)
Sep 2019
-
-$6.91M(-6.8%)
-$26.18M(+13.8%)
Jun 2019
-
-$7.42M(+29.7%)
-$23.00M(+47.6%)
Mar 2019
-
-$5.72M(-6.9%)
-$15.59M(+57.9%)
Dec 2018
-$20.23M(+6.0%)
-$6.14M(+64.8%)
-$9.87M(+22.4%)
Sep 2018
-
-$3.73M(-14.1%)
-$8.06M(-9.3%)
Dec 2017
-$19.09M(-15.8%)
-
-
Dec 2017
-
-$4.34M(-4.7%)
-$8.89M(+95.3%)
Sep 2017
-
-$4.55M
-$4.55M
Dec 2016
-$22.66M
-
-

FAQ

  • What is TransMedics Group, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for TransMedics Group, Inc.?
  • What is TransMedics Group, Inc. annual EBITDA year-on-year change?
  • What is TransMedics Group, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for TransMedics Group, Inc.?
  • What is TransMedics Group, Inc. quarterly EBITDA year-on-year change?
  • What is TransMedics Group, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for TransMedics Group, Inc.?
  • What is TransMedics Group, Inc. TTM EBITDA year-on-year change?

What is TransMedics Group, Inc. annual EBITDA?

The current annual EBITDA of TMDX is $69.95M

What is the all time high annual EBITDA for TransMedics Group, Inc.?

TransMedics Group, Inc. all-time high annual EBITDA is $69.95M

What is TransMedics Group, Inc. annual EBITDA year-on-year change?

Over the past year, TMDX annual EBITDA has changed by +$77.65M (+1008.05%)

What is TransMedics Group, Inc. quarterly EBITDA?

The current quarterly EBITDA of TMDX is $43.30M

What is the all time high quarterly EBITDA for TransMedics Group, Inc.?

TransMedics Group, Inc. all-time high quarterly EBITDA is $43.30M

What is TransMedics Group, Inc. quarterly EBITDA year-on-year change?

Over the past year, TMDX quarterly EBITDA has changed by +$26.19M (+153.10%)

What is TransMedics Group, Inc. TTM EBITDA?

The current TTM EBITDA of TMDX is $100.30M

What is the all time high TTM EBITDA for TransMedics Group, Inc.?

TransMedics Group, Inc. all-time high TTM EBITDA is $100.30M

What is TransMedics Group, Inc. TTM EBITDA year-on-year change?

Over the past year, TMDX TTM EBITDA has changed by +$59.29M (+144.59%)
On this page